{"id":503056,"date":"2021-06-11T09:04:53","date_gmt":"2021-06-11T13:04:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/"},"modified":"2021-06-11T09:04:53","modified_gmt":"2021-06-11T13:04:53","slug":"worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/","title":{"rendered":"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock"},"content":{"rendered":"
\n

LEXINGTON, Mass., June 11, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that leading proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass Lewis and Co., LLC (Glass Lewis), in addition to the Company\u2019s Board of Directors, have recommended that T2 Biosystems stockholders vote in favor of the proposal to amend the Company\u2019s Certification of Incorporation to increase the number of authorized shares of common stock (the \u201cCharter Amendment Proposal\u201d) at the upcoming annual stockholder meeting to be held on June 25, 2021.<\/p>\n

T2 Biosystems\u2019 President and CEO, John Sperzel, has previously released a statement communicating to stockholders the importance of this year\u2019s proposals and their potential impact on the Company. The video statement can be found on the Investor Relations section of the Company\u2019s website at investors.t2biosystems.com.<\/p>\n

T2 Biosystems, Inc. will be holding its Annual Meeting virtually on June 25, 2021 at 9:00 a.m. Eastern Time at\u00a0www.virtualshareholdermeeting.com\/TTOO2021. T2 Biosystems\u2019 stockholders of record as of April 28, 2021 are entitled to vote at the Annual Meeting. However, all stockholders are encouraged to vote ahead of the meeting, even if you are planning to attend.<\/p>\n

T2 Biosystems\u2019 definitive proxy materials, 2020 Annual Report to Stockholders and other relevant information can be found at\u00a0www.sec.gov.<\/p>\n

If you have any questions about how to vote your shares, or need additional assistance, please contact our proxy solicitor, MacKenzie Partners, toll-free at 1-800-322-2885.<\/p>\n

\n About\u00a0T2 Biosystems<\/strong>
\n
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems\u2019 products include the T2Dx\u00ae<\/sup> Instrument, T2Candida\u00ae<\/sup> Panel, the T2Bacteria\u00ae<\/sup> Panel, the T2Resistance\u00ae<\/sup> Panel, and the T2SARS-CoV-2\u2122 Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR\u00ae<\/sup>) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris\u2122 Panel, and T2Lyme\u2122 Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.<\/p>\n

\n Forward-Looking Statements<\/strong>
\n
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the stockholder proposals and their potential impact, as well as statements that include the words \u201cexpect,\u201d \u201cintend,\u201d \u201cplan\u201d, \u201cbelieve\u201d, \u201cproject\u201d, \u201cforecast\u201d, \u201cestimate,\u201d \u201cmay,\u201d \u201cshould,\u201d \u201canticipate,\u201d and similar statements of a future or forward looking nature. These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, (i) any inability to (a) realize anticipated benefits from commitments, contracts or products; (b) successfully execute strategic priorities; (c) bring products to market; (d) expand product usage or adoption; (e) obtain customer testimonials; (f) accurately predict growth assumptions; (g) realize anticipated revenues; (h) incur expected levels of operating expenses; or (i) increase the number of high-risk patients at customer facilities; (ii) failure of early data to predict eventual outcomes; (iii) failure to make or obtain anticipated FDA filings or clearances within expected time frames or at all; or (iv) the factors discussed under Item 1A. “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the U.S. Securities and Exchange Commission, or SEC, on March 31, 2021, and other filings the Company makes with the SEC from time to time. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While the Company may elect to update such forward-looking statements at some point in the future, unless required by law, it disclaims any obligation to do so, even if subsequent events cause its views to change. Thus, no one should assume that the Company\u2019s silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this press release.<\/p>\n

\n Important Information<\/strong>
\n
The Company, its directors, director nominees and certain of its executive officers are participants in the solicitation of proxies from stockholders in respect of the Annual Meeting. The Company has filed a definitive proxy statement and associated proxy card in connection with the solicitation of proxies for the Annual Meeting with the SEC. Details concerning the nominees of the Company\u2019s board of directors for election at the Annual Meeting are set forth in the definitive proxy statement. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY\u2019S DEFINITIVE PROXY STATEMENT AND ANY SUPPLEMENTS THERETO, AS THEY CONTAIN IMPORTANT INFORMATION. Information regarding the identity of the Company\u2019s participants and their respective interests in the matters to be voted on at the Annual Meeting, by security holdings or otherwise, are set forth in the definitive proxy statement and other documents filed with the SEC in connection with the Annual Meeting. Investors and stockholders can obtain a copy of the definitive proxy statement and other documents filed by the Company free of charge from the SEC\u2019s website at www.sec.gov. The Company\u2019s stockholders can also obtain, without charge, a copy of the definitive proxy statement and other relevant filed documents from the \u201cSEC Filings\u201d section of the Company\u2019s website at\u00a0www.t2biosystems.com<\/a><\/p>\n

\n Media Contact:<\/strong>
\n
Gina Kent,\u00a0Vault Communications
gkent@vaultcommunications.com<\/a>
610-455-2763<\/p>\n

\n Investor Contact:<\/strong>
\n
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com<\/a>
<\/a>415-937-5406<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LEXINGTON, Mass., June 11, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that leading proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass Lewis and Co., LLC (Glass Lewis), in addition to the Company\u2019s Board of Directors, have recommended that T2 Biosystems stockholders vote in favor of the proposal to amend the Company\u2019s Certification of Incorporation to increase the number of authorized shares of common stock (the \u201cCharter Amendment Proposal\u201d) at the upcoming annual stockholder meeting to be held on June 25, 2021. T2 Biosystems\u2019 President and CEO, John Sperzel, has previously released a statement communicating to stockholders the importance of this year\u2019s proposals and their potential impact on … <\/p>\n

Continue reading “World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-503056","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nWorld\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., June 11, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that leading proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass Lewis and Co., LLC (Glass Lewis), in addition to the Company\u2019s Board of Directors, have recommended that T2 Biosystems stockholders vote in favor of the proposal to amend the Company\u2019s Certification of Incorporation to increase the number of authorized shares of common stock (the \u201cCharter Amendment Proposal\u201d) at the upcoming annual stockholder meeting to be held on June 25, 2021. T2 Biosystems\u2019 President and CEO, John Sperzel, has previously released a statement communicating to stockholders the importance of this year\u2019s proposals and their potential impact on … Continue reading "World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-11T13:04:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock\",\"datePublished\":\"2021-06-11T13:04:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/\"},\"wordCount\":1048,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/\",\"name\":\"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=\",\"datePublished\":\"2021-06-11T13:04:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/","og_locale":"en_US","og_type":"article","og_title":"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock - Market Newsdesk","og_description":"LEXINGTON, Mass., June 11, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that leading proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass Lewis and Co., LLC (Glass Lewis), in addition to the Company\u2019s Board of Directors, have recommended that T2 Biosystems stockholders vote in favor of the proposal to amend the Company\u2019s Certification of Incorporation to increase the number of authorized shares of common stock (the \u201cCharter Amendment Proposal\u201d) at the upcoming annual stockholder meeting to be held on June 25, 2021. T2 Biosystems\u2019 President and CEO, John Sperzel, has previously released a statement communicating to stockholders the importance of this year\u2019s proposals and their potential impact on … Continue reading \"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-11T13:04:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock","datePublished":"2021-06-11T13:04:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/"},"wordCount":1048,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/","name":"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=","datePublished":"2021-06-11T13:04:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1Mjc2NiM0MjM4MjQyIzIwMDU4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/worlds-leading-proxy-advisory-firms-iss-and-glass-lewis-recommend-t2-biosystems-stockholders-vote-for-the-charter-amendment-proposal-to-increase-the-number-of-auth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"World\u2019s Leading Proxy Advisory Firms ISS and Glass Lewis Recommend T2 Biosystems Stockholders Vote \u201cFOR\u201d the Charter Amendment Proposal \u2013 To Increase the Number of Authorized Shares of Common Stock"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/503056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=503056"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/503056\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=503056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=503056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=503056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}